MannKind Corp
MNKD
#4977
Rank
ยฃ1.29 B
Marketcap
ยฃ4.22
Share price
-0.17%
Change (1 day)
-10.34%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): ยฃ23.74 Million

According to MannKind Corp's latest financial reports the company's current earnings are ยฃ0.31 Billion. In 2024 the company made an earning of ยฃ22.3 Million, an increase over its 2023 earnings that were of -ยฃ7.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ23.74 M6.46%
2024 ยฃ22.3 M-394.09%
2023 -ยฃ7.59 Million-88.13%
2022 -ยฃ63.87 Million8%
2021 -ยฃ59.14 Million40.84%
2020 -ยฃ41.99 Million10.7%
2019 -ยฃ37.93 Million-40.16%
2018 -ยฃ63.39 Million-26.04%
2017 -ยฃ85.71 Million-193.33%
2016 ยฃ91.82 M-134.11%
2015 -ยฃ0.27 Billion85.72%
2014 -ยฃ0.15 Billion3.6%
2013 -ยฃ0.14 Billion12.79%
2012 -ยฃ0.13 Billion5.58%
2011 -ยฃ0.12 Billion-5.72%
2010 -ยฃ0.13 Billion-22.51%
2009 -ยฃ0.17 Billion-27.37%
2008 -ยฃ0.23 Billion3.36%
2007 -ยฃ0.22 Billion27.18%
2006 -ยฃ0.17 Billion101.63%
2005 -ยฃ83.55 Million50.46%
2004 -ยฃ55.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.66 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ15.23 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
ยฃ16.44 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.87 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
ยฃ0.54 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-ยฃ83.15 Million-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA